Peripartum Cardiomyopathy : A Rare Case Report And A Brief Review of Literature

International Journal of Medical Science

© 2020 by SSRG - IJMS Journal

Volume 7 Issue 2

Year of Publication : 2020

Authors : Dr. Vajed Mogal, Dr. Sandeep Sanap

10.14445/23939117/IJMS-V7I2P101

How to Cite?

Dr. Vajed Mogal, Dr. Sandeep Sanap, "Peripartum Cardiomyopathy : A Rare Case Report And A Brief Review of Literature," SSRG International Journal of Medical Science, vol. 7,  no. 2, pp. 1-3, 2020. Crossref, https://doi.org/10.14445/23939117/IJMS-V7I2P101

Abstract:

Peripartum cardiomyopathy (PPCM) is a rare form of heart failure with a reported incidence of 1 per 3000 to 1 per 4000 live births and a fatality rate of 20%-50%. Onset is usually between the last month of pregnancy and up to 5 months up postpartum in previously healthy women. Peripartum cardiomyopathy is a relatively rare disease, which can have devasting consequences and should be promptly identified and correctly treated. Overall prognosis is good in majority of the cases, although some patients may progress to irreversible heart failure. We describe the case of a 22 year-old-female who presented with dyspnoea, fatiguability, peripheral edema and abdominal distension. Early diagnosis is important and effective treatment reduces mortality rates and increases the chance of complete recovery of ventricular systolic function.

Keywords:

Peripartum cardiomyopathy, heart failure, echocardiography.

References:

[1] Silwa K, HilfikerKleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and
therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12: 767–78.
[2] Hamilton BE, Martin JA, Ventura SJ, Sutton PD. Births: preliminary data for 2007. Natl Vital Stat Rep. 2009; 57: 1–23.
[3] Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia, PA: Saunders; 2007. P. xx–yy.
[4] Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation 1971 Dec;44(6):1053–61.
[5] Pearson GO, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000 Mar 1;283(9):1183–8.
[6] Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368(9536): 687-93.
[7] Marx JA, Hockberger RS, Walls RM, eds. Rosen’s emergency medicine: concepts and clinical practice. 6th ed. Philadelphia,PA: Elsevier Health Sciences; 2006.
[8] Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007 Jun 12;118(3):295–303.
[9] Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gnecol 2002; 186(5): 1005-10.
[10] Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy. Clinical Characteristics and a comparison between early and late presentation. Circulation 2005; 111(16): 2050-5.
[11] Cunningham GF, Gant NF, Leveno KJ, Gilstrap III LC, Hauth JC, Wenstrom KD, eds. Williams Obstetrics. 21st ed. New York: McGraw-Hill; 2001. p 1141–514.
[12] Felker G, Thompson R, Hare J, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000 Apr 13;342(15):1077–84.
[13] Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, The Permanente Journal/ Fall 2009/ Volume 13 No. 4 Peripartum Cardiomyopathy: Case Reports Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000 Mar 1;35(3):701–5.
[14] Cénac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. Int J Cardiol 1992 Jul;36(1):57–9.
[15] Fett JD, Ansari AA, Sundstrom JB, Combs GF. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardio 2002 Dec;86(2–3):311–6.
[16] Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 2000; 91(1): 22-8.
[17] Ray P, Murphy G, Shutt L. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth 2004; 93: 42839.
[18] Davidson NM, Parry EH. The etiology of peripartum cardiac failure. Am Heart J 1979 Apr;97(4):535–6.
[19] Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J 1995 Oct;130(4):860–70.
[20] Dorbala S, Brozena S, Zeb S, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr 2005; 18(1): 45-8.
[21] Fett J. The role of MRI in peripartum cardiomyopathy. Int J Cardiol 2008 Aug 5.
[22] Ardehali H, Kasper EK, Baughman KL. Peripartum cardiomyopathy. Minerva Cardioangiol 2003; 51(1): 41-8.
[23] Mishra TK, Swain S, Routray SN. Peripartum cardiomyopathy. Int J Gynaecol Obstet 2006; 95(2): 104-9.